S
ONE TO WATCH:
Mary Szela SVP, Pharma Operations, Abbott
With more than 20 years at Abbott, Szela, age 45, is making her way through the ranks. She started her career at the University of Illinois Hospital, and then headed up Abbott's hospital products division (now Hospira). Since joining the pharma side, she's led commercialization on several brands, including Humira, and in 2007 was named to lead the Rx biz.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.